Delivery Order SPE2DB25D3012-SPE2DB26FWVUS
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Verquvo 5 mg tablets (14-count units) with a ceiling value of $7,605.92 under a firm fixed price contract. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 26, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a $2,886.90 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Verquvo 2.5 mg tablets (30-count units). This firm fixed price, non-set-aside contract is expected to be completed by August 18, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $7,091.65 delivery order to AmerisourceBergen Drug Corp for VERQUVO 5 mg tablets (14-count packaging) on November 3, 2025, with completion targeted for November 4, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor...
- The Defense Logistics Agency awarded a delivery order valued at $3,721.73 to AmerisourceBergen Drug Corp for Verquvo 5 mg tablets (14-count packaging) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order is non-set-aside and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this requirement as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Verquvo 10 mg tablets (quantity 90) at a firm fixed price of $12,569.21, with completion targeted for September 3, 2025. This contract represents a non-set-aside, competitively awarded delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The performance location is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency awarded a $1,243.00 delivery order to AmerisourceBergen Drug Corp for VERQUVO 10 mg tablets (30-count units) on April 22, 2025, with completion scheduled for April 23, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The pharmaceutical products will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,761.08 to AmerisourceBergen Drug Corp for the supply of Verquvo 2.5 mg tablets (30-count packaging) on August 26, 2025, with an ultimate completion date of August 27, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for VERQUVO 10 mg tablets (30-count units) valued at $2,749.50 under a firm fixed-price contract type. The award was made on June 16, 2025, with an ultimate completion date of June 17, 2025. This delivery order is not set-aside and was competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. AmerisourceBergen Drug Corp serves as a critical vendor within the federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $2,415.96 to AmerisourceBergen Drug Corp for Verquvo 5 mg tablets (14-count packaging) on September 12, 2025, with completion scheduled for September 15, 2025. This firm fixed-price delivery order is unclassified and carries no set-aside designation, indicating competitive award status. The award leverages AmerisourceBergen's position as a major pharmaceutical distributor and represents a child order under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Verquvo 5 mg tablets (30-count package) with a ceiling value of $1,052.64 and firm fixed pricing. This non-set-aside, competitively awarded delivery order is scheduled for completion by September 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB26FWVUSDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Verquvo 5 mg tablets (quantity 30) under a firm fixed-price contract valued at $2,517.07. The order is set to be completed by November 7, 2025, with fulfillment occurring at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is competitively awarded with no set-aside designation and represents a routine pharmaceutical procurement transaction within the federal medical supply chain. This delivery order is issued as a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's comprehensive IDC vehicle enables the supply of a broad range of pharmaceutical products, generic and brand-name medications, vaccines, and specialized medical supplies to support military healthcare operations globally. The provision of Verquvo, a cardiac medication, exemplifies the specialized pharmaceutical support the company provides across multiple therapeutic domains under this strategic federal contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 11/6/25 |